Inventor · disambiguated record
Abraham Thomas
Also filed as: THOMAS ABRAHAM
35 granted patents·6 pending applications·162 citations·filing 1997–2019
96Inventor score
Files withGLENMARK PHARMACEUTICALS SA23KUMAR SUKEERTHI3AFG IND INC2CHAUDHARI SACHIN SUNDARLAL2LINGAM V S PRASADA RAO2
Top patents by PatentIndex Score
41 records- 0190US6750224B1Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatmentWOCKHARDT LTD·Filed 2000·Granted Jun 15, 2004·30 cites·10 claims
- 0287US8507503B2Thienopyrimidinedione derivatives as TRPA1 modulatorsKUMAR SUKEERTHI·Filed 2010·Granted Aug 13, 2013·13 cites·31 claims
- 0384US7230002B2Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereofGLENMARK PHARMACEUTICALS LTD·Filed 2005·Granted Jun 12, 2007·6 cites·29 claims
- 0484US7205323B2Dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparationGLENMARK PHARMACEUTICALS SA·Filed 2005·Granted Apr 17, 2007·8 cites·51 claims
- 0582US8592398B22-amino-4-arylthiazole compounds as TRPA1 antagonistsKUMAR SUKEERTHI·Filed 2011·Granted Nov 26, 2013·8 cites·8 claims
- 0679US7951814B2Quinazolinedione derivatives as TRPA1 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2009·Granted May 31, 2011·4 cites·23 claims
- 0777US8575178B2Isothiazolo-pyrimidinedione derivatives as TRPA1 modulatorsKUMAR SUKEERTHI·Filed 2010·Granted Nov 5, 2013·5 cites·15 claims
- 0877US7538128B2Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing themGLENMARK PHARMACEUTICALS SA·Filed 2007·Granted May 26, 2009·3 cites·47 claims
- 0976US6352780B1Coating for glass substrate for anti-reflective properties with abrasion, chemical and UV resistanceAFG IND INC·Filed 2000·Granted Mar 5, 2002·15 cites·23 claims
- 1075US9186360B2Treatment of respiratory disorders using TRPA1 antagonistsKHAIRATKAR-JOSHI NEELIMA·Filed 2012·Granted Nov 17, 2015·6 cites·7 claims
- 1175US8623880B2Fused pyrimidine-dione derivatives as TRPA1 modulatorsCHAUDHARI SACHIN SUNDARLAL·Filed 2010·Granted Jan 7, 2014·6 cites·23 claims
- 1270US7524844B2Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing themGLENMARK PHARMACEUTICALS SA·Filed 2007·Granted Apr 28, 2009·1 cites·51 claims
- 1369US8987278B2Thienopyrimidinedione derivatives as TRPA1 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Mar 24, 2015·1 cites·29 claims
- 1469US8349846B2Fused pyrimidine derivatives as TRPV3 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2009·Granted Jan 8, 2013·2 cites·25 claims
- 1568US8404727B2Pharmaceutical composition that includes a dipeptidyl peptidase-IV inhibitorDHUPPAD ULHAS·Filed 2010·Granted Mar 26, 2013·5 cites·9 claims
- 1668US6040378ACoating for glass substrate for anti-reflective properties with abrasion, chemical and UV resistanceAFG IND INC·Filed 1998·Granted Mar 21, 2000·25 cites·6 claims
- 1767US8119647B2Fused pyrimidineone compounds as TRPV3 modulatorsLINGAM PRASADA RAO V S·Filed 2009·Granted Feb 21, 2012·2 cites·50 claims
- 1865US9682977B2Bicyclic heteroaryl indole analogues useful as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2014·Granted Jun 20, 2017·1 cites·11 claims
- 1965US9000159B2Fused pyrimidine-dione derivatives as TRPA1 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Apr 7, 2015·1 cites·16 claims
- 2063US10336688B2Carbocyclic compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Jul 2, 2019·0 cites·10 claims
- 2162US10988467B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2019·Granted Apr 27, 2021·0 cites·9 claims
- 2259US8518955B2Fused pyrimidineone compounds as TRPV3 modulatorsLINGAM V S PRASADA RAO·Filed 2012·Granted Aug 27, 2013·1 cites·22 claims
- 2358US8487121B2Chromane derivatives as TRPV3 modulatorsLINGAM V S PRASADARAO·Filed 2008·Granted Jul 16, 2013·1 cites·47 claims
- 2457US6429762B1Data communication isolation transformer with improved common-mode attenuationCOMPAQ INFORMATION TECHNOLOGIE·Filed 1997·Granted Aug 6, 2002·18 cites·21 claims
- 2557US2008108646A1Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatmentWOCKHARDT LTD·Filed 2007·Application pending·0 cites
- 2654US9073955B22-amino-4-arylthiazole compounds as TRPA1 antagonistsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Jul 7, 2015·0 cites·6 claims
- 2754US8889862B22-amino-4-arylthiazole compounds as TRPA1 antagonistsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Nov 18, 2014·0 cites·6 claims
- 2853US10344024B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Jul 9, 2019·0 cites·9 claims
- 2953US9458173B2Amides of 2-amino-4-arylthiazole compounds and their saltsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Oct 4, 2016·0 cites·28 claims
- 3049US9975887B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted May 22, 2018·0 cites·27 claims
- 3149US9474758B2Thienopyrimidinedione derivatives as TRPA1 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2015·Granted Oct 25, 2016·0 cites·8 claims
- 3249US7893103B2Processes for the preparation of DPP IV inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2007·Granted Feb 22, 2011·0 cites·11 claims
- 3348US8344010B2Fused imidazole derivatives as TRPV3 antagonistGLENMARK PHARMACEUTICALS SA·Filed 2009·Granted Jan 1, 2013·0 cites·40 claims
- 3447US2011237659A1Chromenone derivatives as trpv3 antagonistsGLENMARK PHARMACEUTICALS SA·Filed 2009·Application pending·0 cites
- 3546US2012178766A1Furopyrimidinedione derivatives as trpai modulatorsCHAUDHARI SACHIN SUNDARLAL·Filed 2010·Application pending·0 cites
- 3645US8492568B2Chromane derivatives as TRPV3 modulatorsLINGAM V S PRASADA RAO·Filed 2009·Granted Jul 23, 2013·0 cites·19 claims
- 3745US2018368948A1Geared Orthodontic Buccal TubeOKLAHOMA MED RES FOUND·Filed 2016·Application pending·0 cites
- 3843US10189775B2Carbocyclic compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Jan 29, 2019·0 cites·15 claims
- 3941US2020247800A1Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 4040US2008182851A1Acetylene derivatives as stearoyl coa desaturase inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2007·Application pending·0 cites
- 4128US9718817B2Aryl and heteroaryl ether compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2015·Granted Aug 1, 2017·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Abraham Thomas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →